Erion Rreka
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Erion Rreka has a total of 108 co-authors. Here are the top co-authors by number of shared publications:
- Davide Ghinolfi
Division of Hepatic Surgery and Liver Transplantation, University Hospital of Pisa, Pisa, Italy
5 shared publications Franco Filipponi
Hepatobiliary surgery and liver transplantation, University of Pisa Medical School Hospital, Pisa, Italy
4 shared publicationsPaola Carrai
Hepatobiliary Surgery and Liver Transplantation,University of Pisa Medical School Hospital,Pisa,Italy
4 shared publicationsPaolo De Simone
Hepatobiliary surgery and liver transplantation, University of Pisa Medical School Hospital, Pisa, Italy
4 shared publications- Quirino Lai
General Surgery and Organ Transplantation Unit, Sapienza University, AOU Policlinico Umberto I, Rome, Italy
4 shared publications Daniele Pezzati
Hepatobiliary Surgery and Liver Transplantation,University of Pisa Medical School Hospital,Pisa,Italy
3 shared publications
Latest Publications
- 5 June 2019
- Published by Wolters Kluwer Health in Liver Transplantation
- Vol. 25 (9) , 1439-1444
Nonagenarian Grafts for Liver Transplantation
- 5 June 2019
- Published by Wolters Kluwer Health in Liver Transplantation
- Vol. 25 (9) , 1439-1444
Nonagenarian Grafts for Liver Transplantation
- 28 February 2019
- Published by Wolters Kluwer Health in Liver Transplantation
- Vol. 25 (3) , 436-449
Pilot, Open, Randomized, Prospective Trial for Normothermic Machine Perfusion Evaluation in Liver Transplantation From Older Donors
Ex situ normothermic machine perfusion (NMP) might minimize ischemia/reperfusion injury (IRI) of liver grafts. In this study, 20 primary liver transplantation recipients of older grafts (≥70 years) were randomized 1:1 to NMP or cold storage (CS) groups. The primary study endpoint was to evaluate graft and patient survival at 6 months posttransplantation. The secondary endpoint was to evaluate liver and bile duct biopsies; IRI by means of peak transaminases within 7 days after surgery; and incidence of biliary complications at month 6. Liver and bile duct biopsies were collected at bench surgery, end of ex situ NMP, and end of transplant surgery. Interleukin (IL) 6, IL10, and tumor necrosis factor α (TNF‐α) perfusate concentrations were tested during NMP. All grafts were successfully transplanted. Median (interquartile range) posttransplant aspartate aminotransferase peak was 709 (371‐1575) IU/L for NMP and 574 (377‐1162) IU/L for CS (P = 0.597). There was 1 hepatic artery thrombosis in the NMP group and 1 death in the CS group. In NMP, we observed high TNF‐α perfusate levels, and these were inversely correlated with lactate (P < 0.001). Electron microscopy showed decreased mitochondrial volume density and steatosis and an increased volume density of autophagic vacuoles at the end of transplantation in NMP versus CS patients (P < 0.001). Use of NMP with older liver grafts is associated with histological evidence of reduced IRI, although the clinical benefit remains to be demonstrated.
- 28 February 2019
- Published by Wolters Kluwer Health in Liver Transplantation
- Vol. 25 (3) , 436-449
Pilot, Open, Randomized, Prospective Trial for Normothermic Machine Perfusion Evaluation in Liver Transplantation From Older Donors
Ex situ normothermic machine perfusion (NMP) might minimize ischemia/reperfusion injury (IRI) of liver grafts. In this study, 20 primary liver transplantation recipients of older grafts (≥70 years) were randomized 1:1 to NMP or cold storage (CS) groups. The primary study endpoint was to evaluate graft and patient survival at 6 months posttransplantation. The secondary endpoint was to evaluate liver and bile duct biopsies; IRI by means of peak transaminases within 7 days after surgery; and incidence of biliary complications at month 6. Liver and bile duct biopsies were collected at bench surgery, end of ex situ NMP, and end of transplant surgery. Interleukin (IL) 6, IL10, and tumor necrosis factor α (TNF‐α) perfusate concentrations were tested during NMP. All grafts were successfully transplanted. Median (interquartile range) posttransplant aspartate aminotransferase peak was 709 (371‐1575) IU/L for NMP and 574 (377‐1162) IU/L for CS (P = 0.597). There was 1 hepatic artery thrombosis in the NMP group and 1 death in the CS group. In NMP, we observed high TNF‐α perfusate levels, and these were inversely correlated with lactate (P < 0.001). Electron microscopy showed decreased mitochondrial volume density and steatosis and an increased volume density of autophagic vacuoles at the end of transplantation in NMP versus CS patients (P < 0.001). Use of NMP with older liver grafts is associated with histological evidence of reduced IRI, although the clinical benefit remains to be demonstrated.
- Open Access
- 1 November 2018
- Published by Elsevier in Digestive and Liver Disease
- Vol. 50 (11) , 1105-1114
Recurrence of hepatocellular carcinoma after direct acting antiviral treatment for hepatitis C virus infection: Literature review and risk analysis
- 1 November 2018
- Published by Elsevier in Digestive and Liver Disease
- Vol. 50 (11) , 1105-1114
Open AccessRecurrence of hepatocellular carcinoma after direct acting antiviral treatment for hepatitis C virus infection: Literature review and risk analysis
- 15 October 2018
- Published by Frontiers Media SA in Transplant International
- Vol. 32 (2) , 193-205
Dual aortic and portal perfusion at procurement prevents ischaemic-type biliary lesions in liver transplantation when using octogenarian donors: a retrospective cohort study
We read with great interest the study by Pratschke et al. “Association between donor age and risk of graft failure after liver transplantation: An analysis of the Eurotransplant database ‐ a retrospective cohort study”. The study analyzed a large dataset from Eurotransplant and included a final sample of 8,351 patients undergoing liver transplantation between January 2000 and July 2014, of whom 252 (3.0%) were transplanted with octogenarian, brain‐dead donor grafts. Unfortunately, the paper raises several concerns from a methodological point of view. Although the initial population consisted of 26,294 subjects, a total of 68.2% was eventually excluded from analysis.
- 15 October 2018
- Published by Frontiers Media SA in Transplant International
- Vol. 32 (2) , 193-205
Dual aortic and portal perfusion at procurement prevents ischaemic-type biliary lesions in liver transplantation when using octogenarian donors: a retrospective cohort study
We read with great interest the study by Pratschke et al. “Association between donor age and risk of graft failure after liver transplantation: An analysis of the Eurotransplant database ‐ a retrospective cohort study”. The study analyzed a large dataset from Eurotransplant and included a final sample of 8,351 patients undergoing liver transplantation between January 2000 and July 2014, of whom 252 (3.0%) were transplanted with octogenarian, brain‐dead donor grafts. Unfortunately, the paper raises several concerns from a methodological point of view. Although the initial population consisted of 26,294 subjects, a total of 68.2% was eventually excluded from analysis.
- 1 August 2018
- Published by Wolters Kluwer Health in Annals of Surgery
- Vol. 268 (2) , 325-331
Use of Elderly Donors in Liver Transplantation
Objective: To evaluate the use of elderly donors in liver transplantation (LT) and identify risk factors associated with a worse outcome. Summary Background Data: Use of livers from very old donors could expand the donor pool but is not universally implemented. Methods: This is a retrospective, single-center medical record review. From January 2001 to December 2014, 1354 LTs were performed. After exclusion of donors P = 0.3), HCV-related death (7.6 vs. 8.7%; P = 0.6), vascular (5.8 vs. 5.0%; P = 0.7), and biliary complications (16.5 vs. 18.6%; P = 0.4). On multivariate analysis, independent risk factors for graft loss were: HCV-positive recipient (HR = 2.1; 95% CI = 1.6–2.7; P < 0.001), donor age (HR = 1.0; 95% CI = 1.0–1.0; P < 0.001), cold ischemia time (HR = 1.0; 95% CI = 1.0–1.0; P = 0.042), and donor history of diabetes mellitus (HR = 1.48; 95% CI = 1.03–2.13; P = 0.036). Conclusions: Use of elderly donors is not associated per se with an increased risk of vascular and biliary complications. In the presence of cold ischemia time and diabetes mellitus, appropriate donor-to-recipient matching is warranted.
- 1 August 2018
- Published by Wolters Kluwer Health in Annals of Surgery
- Vol. 268 (2) , 325-331
Use of Elderly Donors in Liver Transplantation
Objective: To evaluate the use of elderly donors in liver transplantation (LT) and identify risk factors associated with a worse outcome. Summary Background Data: Use of livers from very old donors could expand the donor pool but is not universally implemented. Methods: This is a retrospective, single-center medical record review. From January 2001 to December 2014, 1354 LTs were performed. After exclusion of donors P = 0.3), HCV-related death (7.6 vs. 8.7%; P = 0.6), vascular (5.8 vs. 5.0%; P = 0.7), and biliary complications (16.5 vs. 18.6%; P = 0.4). On multivariate analysis, independent risk factors for graft loss were: HCV-positive recipient (HR = 2.1; 95% CI = 1.6–2.7; P < 0.001), donor age (HR = 1.0; 95% CI = 1.0–1.0; P < 0.001), cold ischemia time (HR = 1.0; 95% CI = 1.0–1.0; P = 0.042), and donor history of diabetes mellitus (HR = 1.48; 95% CI = 1.03–2.13; P = 0.036). Conclusions: Use of elderly donors is not associated per se with an increased risk of vascular and biliary complications. In the presence of cold ischemia time and diabetes mellitus, appropriate donor-to-recipient matching is warranted.
- 7 November 2017
- Published by AME Publishing Company in Translational Gastroenterology and Hepatology
- Vol. 2 (11) , 87
Perfusion machines and hepatocellular carcinoma: a good match between a marginal organ and an advanced disease?
Hepatocellular carcinoma (HCC) accounts for 90% of primary liver cancers, is the second leading cause of cancer-related deaths and the leading cause of death in patients with cirrhosis. Liver transplantation (LT) represents the ideal treatment for selected patients as it removes both the tumor and the underlying cirrhotic liver with 5-year survival rates higher than 70%. Unfortunately, due to tumor characteristics, patient co-morbidities or shortage of organs available for transplant, only 20% of patients can undergo curative treatment. Ex situ machine perfusion (MP) is a technology recently introduced that might potentially improve organ preservation, allow graft assessment and increase the pool of available organs. The purpose of this review is to provide an update on the current role of ex situ liver MP in liver transplantation for HCC patients.
- 7 November 2017
- Published by AME Publishing Company in Translational Gastroenterology and Hepatology
- Vol. 2 (11) , 87
Perfusion machines and hepatocellular carcinoma: a good match between a marginal organ and an advanced disease?
Hepatocellular carcinoma (HCC) accounts for 90% of primary liver cancers, is the second leading cause of cancer-related deaths and the leading cause of death in patients with cirrhosis. Liver transplantation (LT) represents the ideal treatment for selected patients as it removes both the tumor and the underlying cirrhotic liver with 5-year survival rates higher than 70%. Unfortunately, due to tumor characteristics, patient co-morbidities or shortage of organs available for transplant, only 20% of patients can undergo curative treatment. Ex situ machine perfusion (MP) is a technology recently introduced that might potentially improve organ preservation, allow graft assessment and increase the pool of available organs. The purpose of this review is to provide an update on the current role of ex situ liver MP in liver transplantation for HCC patients.
- 22 May 2017
- Published by Frontiers Media SA in Transplant International
- Vol. 30 (7) , 737-739
Use of donors with genitourinary malignancies for liver transplantation: a calculated risk?
- 22 May 2017
- Published by Frontiers Media SA in Transplant International
- Vol. 30 (7) , 737-739
Use of donors with genitourinary malignancies for liver transplantation: a calculated risk?
- 1 May 2017
- Published by Elsevier in Transplantation Proceedings
- Vol. 49 (4) , 726-728
Salvage of an Octogenarian Liver Graft Using Normothermic Perfusion: A Case Report
- 1 May 2017
- Published by Elsevier in Transplantation Proceedings
- Vol. 49 (4) , 726-728
Salvage of an Octogenarian Liver Graft Using Normothermic Perfusion: A Case Report